Guardian Wealth Advisors LLC Sells 79 Shares of Cardinal Health, Inc. $CAH

Guardian Wealth Advisors LLC lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 1.2% in the 2nd quarter, Holdings Channel reports. The firm owned 6,664 shares of the company’s stock after selling 79 shares during the quarter. Cardinal Health accounts for approximately 0.7% of Guardian Wealth Advisors LLC’s portfolio, making the stock its 18th biggest position. Guardian Wealth Advisors LLC’s holdings in Cardinal Health were worth $1,120,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Cardinal Health in the first quarter worth approximately $26,000. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC increased its stake in Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the period. GW&K Investment Management LLC increased its stake in Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares during the period. Finally, Harbor Asset Planning Inc. bought a new stake in shares of Cardinal Health during the second quarter worth $49,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Evercore ISI dropped their target price on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 13th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Finally, Robert W. Baird boosted their price target on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a report on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $166.00.

Insider Buying and Selling at Cardinal Health

In related news, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Stock Performance

NYSE CAH opened at $161.83 on Friday. The company has a market capitalization of $38.45 billion, a price-to-earnings ratio of 25.09, a price-to-earnings-growth ratio of 1.37 and a beta of 0.71. The company’s 50-day simple moving average is $152.75 and its two-hundred day simple moving average is $152.88. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same quarter in the prior year, the company earned $1.84 EPS. The company’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.